Delivery Order SPE2DB20D1100-SPE2DB25FD8A2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $2,091.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.54 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhalers (8 grams) with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 230-21 microgram inhalers (12-gram units) with a contract ceiling value of $6,737.52. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) with a ceiling value of $1,814.66. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The ultimate completion date is set for August 18, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,669.86 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhaler 12gm on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a $14,025.54 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm). This is a firm fixed price delivery order with no set-aside designation, issued as a competitively awarded contract. The order is scheduled for ultimate completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $2,210.11 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside contract utilized firm fixed pricing and was performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD8A2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 45/21 mcg inhalers (12 gm) with a ceiling value of $6,252.22. This firm fixed-price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Advair inhalers represents a routine pharmaceutical fulfillment under this framework contract, consistent with AmerisourceBergen's role as a primary pharmaceutical distributor for federal defense medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 8/1/25 |